Anna Chamorro
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- SARS-CoV-2 detection and testing
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 11
- HIV/AIDS drug development and treatment 4
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 detection and testing 1
-
- Parasites and Host Interactions 7
- Co-authors
- Bonaventura Clotet (10 shared papers)Sebastián Videla (3 shared papers)Guillem Sirera (3 shared papers)Ariadna Torrella (1 shared paper)Ignacio Martínez‐Zalacaín (1 shared paper)Eva Castellà (1 shared paper)Jorge Carrillo (4 shared papers)Eugènia Negredo (1 shared paper)
- Journals
- Clinical Microbiology and Infection (3 papers)Scientific Reports (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Life Science Alliance (1 paper)Open Forum Infectious Diseases (1 paper)
- Partner nations
- SpainUnited StatesEgypt
In The Last Decade
Anna Chamorro
29 papers receiving 487 citations
Peers
Comparison fields: 5 of 42
- Infectious Diseases 317
- Neurology 89
- Parasitology 42
- Virology 17
- General Dentistry 1
Countries citing papers authored by Anna Chamorro
This map shows the geographic impact of Anna Chamorro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chamorro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chamorro more than expected).
Fields of papers citing papers by Anna Chamorro
This network shows the impact of papers produced by Anna Chamorro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chamorro. The network helps show where Anna Chamorro may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Chamorro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 82 | |
| 2 | 2021 | 80 | |
| 3 | 2021 | 62 | |
| 4 | 2023 | 60 | |
| 5 | 2022 | 24 | |
| 6 | 2023 | 20 | |
| 7 | 2021 | 16 | |
| 8 | 2017 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2024 | 12 | |
| 11 | 2020 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2018 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2025 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2019 | 6 |
About Anna Chamorro
Anna Chamorro is a scholar working on Infectious Diseases, Parasitology, Virology, Neurology and Epidemiology, having authored 31 papers that have together received 498 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (11 papers), Parasites and Host Interactions (7 papers), HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers), Long-Term Effects of COVID-19 (3 papers), Cervical Cancer and HPV Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Infectious Diseases (317 citations), Neurology (89 citations), Parasitology (42 citations), Virology (17 citations) and General Dentistry (1 citation). Anna Chamorro has collaborated with scholars based in Spain, United States and Egypt. Frequent co-authors include Bonaventura Clotet, Sebastián Videla, Guillem Sirera, Ariadna Torrella, Ignacio Martínez‐Zalacaín, Eva Castellà, Jorge Carrillo, Eugènia Negredo, Sílvia Roure and Beatriz Mothe. Their work appears in journals such as Clinical Microbiology and Infection, Scientific Reports, Journal of Antimicrobial Chemotherapy, Life Science Alliance and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.